On September 8th, according to the American news website Marijuana Moment, the state of Massachusetts in the United States has achieved a significant milestone in marijuana sales, with total sales reaching $5 billion. At the same time, the state has also set consecutive monthly sales records.
The Cannabis Control Commission (CCC) in Massachusetts, United States, has announced that retail sales of adult-use marijuana have exceeded $5 billion since the state's recreational marijuana market launched five years ago.
After setting a record-breaking marijuana sales figure for three consecutive months from June to August, the total purchase amount in that state has now reached $5.02 billion. In August alone, sales reached $139.3 million, bringing the total sales for the first eight months of this year to $1.05 billion.
Since 2018, medical marijuana clinics have generated over $1.13 billion in sales, not only for recreational purposes but also for patients and caregivers.
In a press release, Shawn Collins, Executive Director of the CCC, stated,"Despite other states already starting to sell recreational marijuana, Massachusetts has still achieved record-breaking sales. In fact, our neighboring states of Maine, Rhode Island, and Connecticut have also seen record-breaking sales this summer."
Massachusetts reached a milestone in January this year, surpassing $4 billion in adult-use marijuana sales. In a remarkable feat, the state managed to add an additional $1 billion to this figure within a mere eight months, earning accolades for achieving the fastest ever $1 billion sales growth.
New state data from Massachusetts reveals that tax revenue generated from marijuana surpassed that of alcohol for the first time last year.
These record-breaking sales figures are particularly noteworthy as the recreational marijuana market is gradually emerging and expanding in nearby states such as Connecticut, Maryland, New York, and Rhode Island. This could potentially diminish purchases from out-of-state visitors.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
